NCT01594827 Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP) Status COMPLETED Phase PHASE2
NCT01533870 Study in Healthy Volunteers to Investigate the Effects of Rifampin on the Pharmacokinetics of NKTR-118 Status COMPLETED Phase PHASE1
NCT01454076 Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma Status COMPLETED Phase PHASE1
NCT01441206 Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants Status TERMINATED Phase PHASE1
NCT01438515 Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization Status COMPLETED Phase NA
NCT01401933 Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01395927 A Study to Evaluate the Effects of Rifampin on Single-Dose Pharmacokinetics of Canagliflozin in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01349192 Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF) Status TERMINATED Phase PHASE2
NCT01324323 Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT01231542 Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT01218620 Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01147055 Estimation Of Effect Of Rifampin On Pharmacokinetics Of Crizotinib In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01121133 A Study to Assess the Effect of Rifampin on the Metabolism of Navitoclax Status COMPLETED Phase PHASE1
NCT01068756 Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects Status TERMINATED Phase PHASE1
NCT01026415 Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35) Status COMPLETED Phase PHASE1
NCT00964106 Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation Status COMPLETED Phase PHASE1